Skip to content
10-K

Annual Report

MOMENTA PHARMACEUTICALS INC

0001235010-20-000003

← back to feed
Filed
Feb 27, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 13, 2020 117.28M sh
Shares Diluted FY 2019 · Dec 31, 2019 101.82M sh
Shares Diluted FY 2019 · Sep 30, 2019 98.71M sh
Shares Diluted FY 2019 · Jun 30, 2019 98.6M sh
Shares Diluted FY 2019 · Mar 31, 2019 98.2M sh
Shares Diluted FY 2019 · Dec 31, 2018 82.09M sh
Shares Diluted FY 2019 · Sep 30, 2018 77.23M sh
Shares Diluted FY 2019 · Jun 30, 2018 76.54M sh
Shares Diluted FY 2019 · Mar 31, 2018 75.45M sh
Capex FY 2019 · Dec 31, 2019 $1.78M
Capex FY 2019 · Dec 31, 2018 $9.02M
Capex FY 2019 · Dec 31, 2017 $17.13M
Operating Cash Flow FY 2019 · Dec 31, 2019 −$204.8M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$155.59M
Operating Cash Flow FY 2019 · Dec 31, 2017 −$29.09M
Cash And Equivalents FY 2019 · Dec 31, 2019 $382.52M
Cash And Equivalents FY 2019 · Dec 31, 2018 $248.33M
Stockholders Equity FY 2019 · Dec 31, 2019 $454.46M
Stockholders Equity FY 2019 · Dec 31, 2018 $461.01M
Stockholders Equity FY 2019 · Dec 31, 2017 $374.15M
Stockholders Equity FY 2019 · Dec 31, 2016 $371.91M
Current Liabilities FY 2019 · Dec 31, 2019 $106.1M
Current Liabilities FY 2019 · Dec 31, 2018 $51.51M
Total Liabilities FY 2019 · Dec 31, 2019 $163.91M
Total Liabilities FY 2019 · Dec 31, 2018 $70.56M
Current Assets FY 2019 · Dec 31, 2019 $539.13M
Current Assets FY 2019 · Dec 31, 2018 $441.42M
Total Assets FY 2019 · Dec 31, 2019 $618.37M
Total Assets FY 2019 · Dec 31, 2018 $531.56M
Eps Diluted FY 2019 · Dec 31, 2019 −$0.85
Eps Diluted FY 2019 · Sep 30, 2019 −$0.45
Eps Diluted FY 2019 · Jun 30, 2019 −$1.16
Eps Diluted FY 2019 · Mar 31, 2019 −$0.46
Eps Diluted FY 2019 · Dec 31, 2018 −$0.10
Eps Diluted FY 2019 · Sep 30, 2018 −$0.65
Eps Diluted FY 2019 · Jun 30, 2018 −$0.91
Eps Diluted FY 2019 · Mar 31, 2018 −$0.63
Eps Basic FY 2019 · Dec 31, 2019 −$0.85
Eps Basic FY 2019 · Sep 30, 2019 −$0.45
Eps Basic FY 2019 · Jun 30, 2019 −$1.16
Eps Basic FY 2019 · Mar 31, 2019 −$0.46
Eps Basic FY 2019 · Dec 31, 2018 −$0.10
Eps Basic FY 2019 · Sep 30, 2018 −$0.65
Eps Basic FY 2019 · Jun 30, 2018 −$0.91
Eps Basic FY 2019 · Mar 31, 2018 −$0.63
Sga Expense FY 2019 · Dec 31, 2019 $149.82M
Sga Expense FY 2019 · Dec 31, 2018 $85.11M
Sga Expense restated FY 2019 · Dec 31, 2017 $82.21M
Rd Expense FY 2019 · Dec 31, 2019 $144.54M
Rd Expense FY 2019 · Dec 31, 2018 $124M
Rd Expense FY 2019 · Dec 31, 2017 $149.23M
Operating Income FY 2019 · Dec 31, 2019 −$87.28M
Operating Income FY 2019 · Dec 31, 2019 −$298.09M
Operating Income FY 2019 · Sep 30, 2019 −$46.09M
Operating Income FY 2019 · Jun 30, 2019 −$116.63M
Operating Income FY 2019 · Mar 31, 2019 −$48.09M
Operating Income FY 2019 · Dec 31, 2018 −$9.67M
Operating Income FY 2019 · Dec 31, 2018 −$181.33M
Operating Income FY 2019 · Sep 30, 2018 −$51.82M
Operating Income FY 2019 · Jun 30, 2018 −$70.84M
Operating Income FY 2019 · Mar 31, 2018 −$49M
Operating Income FY 2019 · Dec 31, 2017 −$92.55M
Revenue FY 2019 · Dec 31, 2019 $8.18M
Revenue FY 2019 · Dec 31, 2019 $23.87M
Revenue FY 2019 · Sep 30, 2019 $6.39M
Revenue FY 2019 · Jun 30, 2019 $5.18M
Revenue FY 2019 · Mar 31, 2019 $4.11M
Revenue FY 2019 · Dec 31, 2018 $42.82M
Revenue FY 2019 · Dec 31, 2018 $75.59M
Revenue FY 2019 · Sep 30, 2018 $14.88M
Revenue FY 2019 · Jun 30, 2018 $13.03M
Revenue FY 2019 · Mar 31, 2018 $4.85M
Revenue FY 2019 · Dec 31, 2017 $138.88M